🌟 This Week's Spotlight: The Combo Effect in Unlocking Maximum Lifespan

What if the secret to dramatically extending healthspan isn't finding the next wonder drug, but smartly combining the ones we already have? A groundbreaking study published May 28th in Nature Aging suggests exactly that. Researchers from the Max Planck Institute and University College London tested combining rapamycin (the famous longevity molecule targeting mTOCR1) with trametinib (an FDA-approved melanoma drug and a highly specific MEKs inhibitor).

The result? The drug cocktail extended the median and maximum lifespan in both sexes, better than any single drug alone.

In female mice, this combo delivered a 34.9% median lifespan extension—nearly doubling what rapamycin achieved alone. Male mice also showed a 27.4% increase in median lifespan.

This study builds on the previous work showing that joint inhibition of mTOR, MEK and glycogen synthase kinase-3 (GSK-3) using three molecules (rapamycin, trametinib and lithium, respectively), resulted in remarkable 48% median lifespan extension in flies.

What This Means for Us

💊The Combination Future:

This study represents a paradigm shift. Instead of hunting for single "fountain of youth" molecules, we are heading towards precision cocktails—carefully tailored to different genders and individuals, and target aging's multiple pathways simultaneously.

If you're already taking rapamycin for longevity (and some in our community are), this data shows that you might be getting only half the potential benefit. But for now, trametinib isn't available for anti-ageing use, and as a cancer drug, it costs thousands per month. Human trials combining these drugs for aging are the holy grail everyone's waiting for. So far, the rapamycin-only human trial (PEARL trial) data looks promising, showing 48 weeks of intermittent, low-dose rapamycin was "relatively safe" and improved lean tissue mass in women. Now we need the combo studies.

⚠️ For Current & Future Rapamycin Users:

Before anyone gets excited about sourcing rapamycin, let's talk about the risks. While it cuts some cancer risks (~40% reduction in skin squamous cell carcinoma), chronic high-dose use can dampen immune surveillance which can leads to infections (and perhaps other cancers). Also, chronic rapamycin treatment disrupts glucose homeostasis and can lead to high blood glucose.

Watch for red flags: e.g. Mouth ulcers, delayed wound healing, or frequent infections signal your dose is too high. And never drink grapefruit juice with rapamycin—it can boost blood levels to dangerous levels by blocking the enzymes that clear the drug. Work with a medical professional to rack fasting glucose, lipids, renal health, and keep your cancer screenings schedule religiously.

🧬 The Hidden Science (For The Curious Mind)

While the headlines focus on the raw numbers on lifespan extension, the interesting parts of the study lie in the details most people overlooked:

The Blood-Brain Barrier Paradox: Here's where it gets really interesting. Trametinib barely crosses the blood-brain barrier (brain levels are 25-30x lower than blood levels), yet the combination dramatically reduced brain inflammation and glucose uptake. This suggests there are unknown ways that trametinib can impact the brain through other pathways—perhaps by influencing peripheral organs that then send protective signals to the brain.

The Sex Paradox: Both male and female mice lived longer, but they seem to achieved this through different molecular pathways. Gene expression analysis showed that in the spleen, trametinib triggered only 14 gene changes in females versus 2,038 in males. It means that effective aging interventions may require sex-specific optimization in the future.

❓Ask Me Anything✨

Q: "Normally I take coffee late in the day, I can then take melatonin supplement to help with my sleep?" - A question received in the Sleep for Longevity workshop in June.

The short answer: Unlikely.

Because these molecules work through very different mechanisms: Melatonin is a hormone naturally released by the brain to signal circadian timing, helping initiate sleep. It mainly affects when you fall asleep, not how deeply you sleep. Caffeine, on the other hand, blocks adenosine receptors, which are essential for building up the biological pressure to sleep. Caffeine also suppresses the body’s natural melatonin production and can delay your internal clock.

Caffeine’s half-life is 5–6 hours, and its effects can last up to 10 hours, while melatonin, especially in supplement form, peaks in the bloodstream about 30–60 min and clears more quickly. So even if melatonin helps you fall asleep, caffeine still lingers in your system and can still disrupt sleep quality and sleep architecture. There is no peer-reviewed study to test if melatonin can “reverse” caffeine’s effects- the best way to find out is to track your sleep parameters using a wearable at home— look at total sleep time, deep sleep duration, and sleep latency. 🍀

That’s it for this week! The trametinib-rapamycin combo might not be accessible today, but it's showing us where the field is heading. Do you have any questions about this study or longevity research in general? Hit reply and I'll feature the most interesting ones to answer next week.

To vibrant health and long life! ✨🧡

Disclaimer:

This newsletter is for educational purposes only. Please consult your healthcare provider before making any significant dietary or lifestyle changes.

Thank you for reading! Subscribe for free to receive new posts and support my work.

Originally published on Longevity Newsletter